EUVIMEDEUVIMED entdecken
Open Access

Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2

Oncology Research Editorial Office

Oncology Research · 2026 · 34 (5) · 1-10

DOI: 10.32604/or.2026.081624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Oncology Research Editorial Office. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This retracts the article DOI: 10.3727/096504019X15615433287579.].

Zitieren

APA

Oncology Research Editorial Office (2026). Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research, 34(5), 1-10. https://doi.org/10.32604/or.2026.081624

Vancouver

Oncology Research Editorial Office. Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research. 2026;34(5):1-10. doi:10.32604/or.2026.081624

BibTeX
@article{OncologyResearchEditorialOffice2026,
  author = {Oncology Research Editorial Office, Oncology Research Editorial Office},
  title = {Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {5},
  pages = {1--10},
  doi = {10.32604/or.2026.081624}
}
Kostenlos starten →